Skip to main content

Table 1 Clinical and pathology data of subjects

From: Applying low coverage whole genome sequencing to detect malignant ovarian mass

Group

Pathology

Number

Ratio

High grade (34)

Serous cystadenocarcinoma

18

53%

Mucinous cystadenocarcinoma

8

24%

Clear cell carcinoma

3

9%

Yolk sac tumor

1

3%

Adenoid carcinoma of endometrium

2

6%

Granular cell carcinoma

1

3%

Low grade (10)

Borderline serous cystadenoma

4

40%

Borderline mucinous cystadenoma

3

30%

Borderline endometrial carcinoma

2

20%

Benign (19)

Chocolate cyst

9

47%

Teratoma

5

26%

Mucinous cystadenoma

3

16%

Spindle cell tumor

1

5%

Tuberculous granuloma

1

5%

Age (median, range)

 35 (16-53)

Premenopausal

23

35%

 62 (46-83)

Postmenopausal

40

63%

FIGO stage

Ovarian cancers

I

13

30%

II

6

14%

III

18

41%

IV

7

16%